Posted by Michael Wonder on 24 Mar 2021
Post-market review of medicines available on the PBS Opiate Dependence Treatment Program
24 March 2021 - The Department of Health will conduct a post-market review of the medicines available under the Pharmaceutical Benefits Scheme Opiate Dependence Treatment Program including consideration of patient access and affordability.
The Pharmaceutical Benefits Advisory Committee will consider the review.
